Skip to main content
SEPN
NASDAQ Life Sciences

Septerna Posts $18.9M in Third-Quarter Revenue

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$50.74
Mkt Cap
$2.368B
52W Low
$17.55
52W High
$51.1
52W Position info
189% above low
Off High info
at 52W high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

SEPN has more than doubled off its 52-week low of $17.55.

Summary

Septerna reported $18.9M in third-quarter revenue, the first hard top-line number for the quarter, and said its cash position of $565.2M is expected to support operating plans at least into mid-2029. The stock is trading near its 52-week high of $51.10, so expectations are already elevated heading into this print. The revenue line alone doesn't tell us the bottom line — no EPS or guidance was included in the headline, and those are what will decide the reaction. This comes days after the November 4 8-K naming SEP-204, an oral TSHR inhibitor for Graves' disease and thyroid eye disease, as a development candidate, so the pipeline story is the other half of the thesis.

At the time of this announcement, SEPN was trading at $50.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $17.55 to $51.10. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

SEPN - Latest Insights

SEPN
Nov 09, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $50.74
Real-time Price: $41.10 info
Change: -$9.64 (-19%) info
Market Cap: $1.99B info
SEPN
Nov 04, 2026, 8:15 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $43.70
Real-time Price: $41.10 info
Change: -$2.60 (-6%) info
Market Cap: $1.99B info
SEPN
Aug 14, 2026, 5:14 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $45.39
Real-time Price: $41.10 info
Change: -$4.29 (-9%) info
Market Cap: $1.99B info
SEPN
Aug 12, 2026, 6:55 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $48.19
Real-time Price: $41.10 info
Change: -$7.09 (-15%) info
Market Cap: $1.99B info
SEPN
Jun 22, 2026, 4:16 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $34.85
Real-time Price: $41.10 info
Change: +$6.25 (+18%) info
Market Cap: $1.99B info